Jean F. Voltaire

Array ( [id] => 7319346 [patent_doc_number] => 20040225016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Treatment for cancers' [patent_app_type] => new [patent_app_number] => 10/758589 [patent_app_country] => US [patent_app_date] => 2004-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22797 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20040225016.pdf [firstpage_image] =>[orig_patent_app_number] => 10758589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 907503 [patent_doc_number] => 07332525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-19 [patent_title] => 'Method of treatment of prostate cancer and composition for treatment thereof' [patent_app_type] => utility [patent_app_number] => 10/754308 [patent_app_country] => US [patent_app_date] => 2004-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2937 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/332/07332525.pdf [firstpage_image] =>[orig_patent_app_number] => 10754308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469360 [patent_doc_number] => 20040167222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (PABA)' [patent_app_type] => new [patent_app_number] => 10/746206 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8665 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167222.pdf [firstpage_image] =>[orig_patent_app_number] => 10746206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7150925 [patent_doc_number] => 20040171560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Stabilized pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 10/739405 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4389 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171560.pdf [firstpage_image] =>[orig_patent_app_number] => 10739405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346847 [patent_doc_number] => 20040192652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Pharmaceutical combinations and methods for the treatment of leukemia' [patent_app_type] => new [patent_app_number] => 10/729387 [patent_app_country] => US [patent_app_date] => 2003-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7826 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192652.pdf [firstpage_image] =>[orig_patent_app_number] => 10729387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677060 [patent_doc_number] => 20040152766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof' [patent_app_type] => new [patent_app_number] => 10/479441 [patent_app_country] => US [patent_app_date] => 2003-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7789 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152766.pdf [firstpage_image] =>[orig_patent_app_number] => 10479441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7475684 [patent_doc_number] => 20040097902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Circumferential compression device for intracavernosal anesthesia and method for using same' [patent_app_type] => new [patent_app_number] => 10/715084 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2464 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097902.pdf [firstpage_image] =>[orig_patent_app_number] => 10715084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122955 [patent_doc_number] => 20050014784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Endostatin-like angiogenesis inhibition' [patent_app_type] => utility [patent_app_number] => 10/714452 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8027 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014784.pdf [firstpage_image] =>[orig_patent_app_number] => 10714452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4559671 [patent_doc_number] => 07838527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-23 [patent_title] => 'Methods of treating cancer and related methods' [patent_app_type] => utility [patent_app_number] => 10/706328 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17119 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/838/07838527.pdf [firstpage_image] =>[orig_patent_app_number] => 10706328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7988147 [patent_doc_number] => 08076368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Percutaneous absorption type cerebral protective agent' [patent_app_type] => utility [patent_app_number] => 10/579055 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5381 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076368.pdf [firstpage_image] =>[orig_patent_app_number] => 10579055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906279 [patent_doc_number] => 20050101674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'PPMP as a ceramide catabolism inhibitor for cancer treatment' [patent_app_type] => utility [patent_app_number] => 10/712763 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9405 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101674.pdf [firstpage_image] =>[orig_patent_app_number] => 10712763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844473 [patent_doc_number] => 20060122186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia' [patent_app_type] => utility [patent_app_number] => 10/534573 [patent_app_country] => US [patent_app_date] => 2003-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5130 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122186.pdf [firstpage_image] =>[orig_patent_app_number] => 10534573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474586 [patent_doc_number] => 20040122081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Pharmaceutical compositions and methods of using taxane derivatives' [patent_app_type] => new [patent_app_number] => 10/704165 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4596 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122081.pdf [firstpage_image] =>[orig_patent_app_number] => 10704165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918808 [patent_doc_number] => 20050096369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Compositions and methods for treating cellular proliferation disorders' [patent_app_type] => utility [patent_app_number] => 10/701899 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8070 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096369.pdf [firstpage_image] =>[orig_patent_app_number] => 10701899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325358 [patent_doc_number] => 20040138207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Antitumor agents' [patent_app_type] => new [patent_app_number] => 10/476539 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4702 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138207.pdf [firstpage_image] =>[orig_patent_app_number] => 10476539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362092 [patent_doc_number] => 20040091523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Pharmaceutical composition and the process for its preparation' [patent_app_type] => new [patent_app_number] => 10/699043 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2333 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091523.pdf [firstpage_image] =>[orig_patent_app_number] => 10699043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7322532 [patent_doc_number] => 20040137062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Chronotherapy tablet and methods related thereto' [patent_app_type] => new [patent_app_number] => 10/697473 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7615 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137062.pdf [firstpage_image] =>[orig_patent_app_number] => 10697473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 278067 [patent_doc_number] => 07557142 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-07 [patent_title] => 'Therapeutic use of methionine to reduce the toxicity of platinum-containing anti-tumor compounds' [patent_app_type] => utility [patent_app_number] => 10/694448 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 14912 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/557/07557142.pdf [firstpage_image] =>[orig_patent_app_number] => 10694448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7337545 [patent_doc_number] => 20040132825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Methods of treating cancer with HDAC inhibitors' [patent_app_type] => new [patent_app_number] => 10/692523 [patent_app_country] => US [patent_app_date] => 2003-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26514 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132825.pdf [firstpage_image] =>[orig_patent_app_number] => 10692523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688969 [patent_doc_number] => 20060287284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Pharmaceutical composition combining tenatoprazole and an anti-inflamatory agent' [patent_app_type] => utility [patent_app_number] => 10/532041 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2715 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287284.pdf [firstpage_image] =>[orig_patent_app_number] => 10532041 [rel_patent_id] =>[rel_patent_doc_number] =>)